Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 24 Jul 2026 for VYNE Therapeutics Inc., €62k. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
David Domzalski: trading record in brief
All filings by David Domzalski on record concern Yarrow Bioscience, Inc., in the capacity of chief executive. In total, 33 filings cover trades dated from 28 May 2021 to 23 July 2026.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
Most recently, on 24 July 2026, the filings show a share grant worth €62k in Yarrow Bioscience, Inc. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to David Domzalski
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations33 total
79,391 shares@ US$0.89760.23% mcap14.8% of flowCommon StockSEC:0001727794-26-000010:0
14,232 shares@ US$0.59751.8% of flowCommon StockSEC:0001727794-26-000004:0
12,684 shares@ US$0.58011.7% of flowCommon StockSEC:0001727794-26-000002:0
12,676 shares@ US$0.3351.0% of flowCommon StockSEC:0001727794-25-000003:0
12,676 shares@ US$1.655.1% of flowCommon StockSEC:0001415889-25-019056:0
8,681 shares@ US$0.811.8% of flowCommon StockSEC:0001415889-25-015382:0
30,498 shares@ US$1.5811.0% of flowCommon StockSEC:0001415889-25-009629:0
24,536 shares@ US$3.3519.6% of flowCommon StockSEC:0001415889-25-000152:0
3,901 shares@ US$2.101.9% of flowCommon StockSEC:0001415889-24-028073:0
685 shares@ US$1.880.3% of flowCommon StockSEC:0001415889-24-024380:0
935 shares@ US$1.920.4% of flowCommon StockSEC:0001415889-24-019173:0
4,429 shares@ US$2.1592.2% of flowCommon StockSEC:0001415889-24-015370:0
1,004 shares@ US$3.080.7% of flowCommon StockSEC:0001415889-24-010064:0
225,000 shares0Common StockSEC:0001209191-24-000465:0
225,000 shares0Common StockSEC:0001209191-23-058815:0
2,284 shares@ US$2.81351.5% of flowCommon StockSEC:0001209191-23-057220:0
8,549 shares@ US$3.837.7% of flowCommon StockSEC:0001209191-23-051941:0
981 shares@ US$4.100.9% of flowCommon StockSEC:0001209191-23-041094:0
2,766 shares@ US$3.45632.2% of flowCommon StockSEC:0001209191-23-033783:0
2,734 shares@ US$3.081.9% of flowCommon StockSEC:0001209191-23-022790:0
10,685 shares@ US$0.150.4% of flowCommon StockSEC:0001209191-23-001066:0
34,705 shares@ US$0.19771.6% of flowCommon StockSEC:0001209191-22-059425:0
10,683 shares@ US$0.2230.6% of flowCommon StockSEC:0001209191-22-052350:0
10,683 shares@ US$0.3891.0% of flowCommon StockSEC:0001209191-22-040778:0
11,887 shares@ US$0.34630.020% mcap2.1% of flowCommon StockSEC:0001209191-22-033542:0
25 of 33 declarations
